13 August,2024 12:49 PM IST | New Delhi | mid-day online correspondent
The Supreme Court is hearing a plea filed by the Indian Medical Association (IMA) alleging a smear campaign against the Covid vaccination drive and modern systems of medicine. File pic
The Supreme Court on Tuesday closed the contempt proceedings against yoga guru Ramdev, his aide Balkrishna and Patanjali Ayurved Limited after accepting the apology tendered by them in the misleading advertisements case.
"The court has closed the contempt proceedings based on the undertakings given by Ramdev, Balkrishna and Patanjali Ayurved Ltd," said advocate Gautam Talukdar, who represented the yoga guru, Balkrishna and the firm.
A bench of justices Hima Kohli and Ahsanuddin Amanullah had on May 14 reserved its order on the contempt notice issued to Ramdev, Balkrishna and Patanjali Ayurved Ltd in the case.
The Supreme Court is hearing a plea filed by the Indian Medical Association (IMA) alleging a smear campaign against the Covid vaccination drive and modern systems of medicine.
ALSO READ
Jharkhand polls 2024: JMM-led INDIA bloc leading in 50 seats, NDA ahead in 30
Jharkhand polls 2024: CM Hemant Soren ahead by 12,818 votes in Barhait
Wayanad by-polls: Priyanka Gandhi will surpass votes received by Rahul
Jharkhand polls 2024: Jharkhand BJP chief leading by 1,840 votes over CPIML
Delhi air pollution: Air quality slips back to 'severe' with AQI at 420
On February 27, the Supreme Court had issued notices to Patanjali Ayurved and managing director Balkrishna asking why contempt proceedings should not be initiated against them for prima facie violating the firm's undertaking given in the court earlier about advertising of its products and their medicinal efficacy.
The court had on March 19 said it was deemed appropriate to issue a show cause notice to Ramdev as the advertisements issued by Patanjali, which were in the teeth of the undertaking given to the court on November 21, 2023, reflect an endorsement by him.
In its November 21, 2023 order, the top court had noted that the counsel representing Patanjali Ayurved had assured it that "henceforth there shall not be any violation of any law(s), especially relating to advertising or branding of products manufactured and marketed by it and, further, that no casual statements claiming medicinal efficacy or against any system of medicine will be released to the media in any form".
The top court had said Patanjali Ayurved Ltd is "bound down to such assurance".
Non-adherence to the specific assurance and subsequent media statements by the firm had irked the apex court, which later issued notice to them to show cause as to why contempt proceedings be not initiated against them.
(With PTI inputs)